KMTS logo
Kestra Medical Technologies, Ltd.(KMTS)
Closing price · checked 8:28 PM ETAbout this dataData status
$25.10▼-1.53 (-5.75%)
Extended:$25.10+0.00 (+0.00%)· 8:28 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →
KMTS logo

KMTS ROE

Current (TTM)-67.40%
KMTS ROE (-763.99% → -67.40%)
High-resolution chart · PNG

What is roe?

Return on equity.

Kestra Medical Technologies Ltd (KMTS) ranks #3,434 of 3,655 covered stocks by roe, highest first. See the full ranking →

Compare roe

Values are from the market snapshot of . The difference is against KMTS (-64.18%).

KMTS roe history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Kestra Medical Technologies Ltd ROE — Annual fiscal periods
Period endingROEChange
-50.6867%+4.72 pts
-55.4093%−100.36 pts
44.9524%−26.69 pts
71.6444%+2,002.62 pts
-1,930.974%−1,166.99 pts
-763.9876%—

Frequently asked questions: KMTS roe

What is Kestra Medical Technologies Ltd (KMTS)'s current roe?

Kestra Medical Technologies Ltd (KMTS)'s latest reported roe (TTM) is -67.40% as of Nov 21, 2026. Return on equity.

How much historical roe data is available for KMTS?

Stock Alarm Pro provides 6 dated annual fiscal periods observations for Kestra Medical Technologies Ltd (KMTS)'s roe, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

Where does Kestra Medical Technologies Ltd (KMTS) rank by roe?

Kestra Medical Technologies Ltd (KMTS) ranks #3,434 of 3,655 covered stocks by roe, highest first. Based on the market snapshot of Nov 21, 2026.

How can I compare KMTS's roe to peers or set an alert?

You can compare KMTS's roe directly against sector peers (GH, BBIO, GKOS, BTSG) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on KMTS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.